Clinical trials for Liver and bile duct cancer

140 currently recruiting clinical trials
Phase 2 / Phase 3 Liver and bile duct cancer #NCT06109272 #2023-504600-28-00
Hepatocellular carcinoma Locally Advanced Metastatic Unhealthy A B B C None Systemic Treatment-Naive
2 recruiting sites
Abbvie
Phase 2 Pancreas cancer Liver and bile duct cancer #NCT07478523 #2024-517270-23-00
Adenocarcinoma Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma Localized Locally Advanced None Systemic Treatment-Naive Systemic Treatment-Naive
1 recruiting site
CHU de Bordeaux
Phase 2 Breast cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer #NCT06581432 #2023-510429-14-00
HER2 Positive Locally Advanced Metastatic Metastatic Castration-resistant HER2 1 2 3 or more
Systemic Treatment-Naive
4 recruiting sites
Boehringer Ingelheim
Phase 2 Breast cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer Sarcoma and GIST Penile cancer and germ cell tumors Cervical / Vulvar / Vaginal cancer #NCT06760819 #2024-517419-62-00
Stomach Oesogastric junction Esophagus Adenocarcinoma Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma Ampullary carcinoma Gastrointestinal stromal tumor Squamous cell carcinoma Other HER2 Positive Locally Advanced Metastatic Metastatic Castration-resistant HER2 1
Systemic Treatment-Naive
6 recruiting sites
Bayer
Phase 2 Breast cancer Prostate cancer Colon cancer Rectal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer Sarcoma and GIST Thymus cancer Penile cancer and germ cell tumors Cervical / Vulvar / Vaginal cancer #NCT03175224 #2024-514542-37-00
Locally Advanced Metastatic MET 1 2 3 or more
BRAF EGFR KRAS G12C KRAS non G12C NTRK-1/2/3 RET ALK ROS-1 Systemic Treatment-Naive Targeted therapy
5 recruiting sites
Apollomics
Phase 2 Liver and bile duct cancer #NCT06254248 #2024-514400-14-00
Hepatocellular carcinoma Locally Advanced Metastatic Unhealthy A None Transplant Systemic Treatment-Naive
10 recruiting sites
Assistance Publique - Hôpitaux de Paris
Phase 2 Liver and bile duct cancer #NCT07122089
Hepatocellular carcinoma Localized Locally Advanced Unhealthy A None Systemic Treatment-Naive Systemic Treatment-Naive
Immunotherapy Radiotherapy
2 recruiting sites
Centre Eugène Marquis
Phase 2 Pancreas cancer Liver and bile duct cancer Stomach and esophageal cancer Sarcoma and GIST #NCT06333314 #2023-505298-34-00
Stomach Oesogastric junction Soft tissue sarcoma Adenocarcinoma Ampullary carcinoma Locally Advanced Metastatic MSI/dMMR None Systemic Treatment-Naive CPS Negative (< 1) CPS Positive (1 <= X < 5)
Immunotherapy Radiotherapy
6 recruiting sites
UNICANCER
Phase 2 Liver and bile duct cancer #NCT05489211 #2022-000776-19
Cancer des voies biliaires (sous-étude 7)
Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive Antibody Drug Conjugates (ADC)
2 recruiting sites
AstraZeneca
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT03767075 #2024-514238-19-00
Module 2 bras 2B, Module 3 bras 3A et 3C
Locally Advanced Metastatic Metastatic Castration-resistant EGFR FGFR MET 1 2 3 or more
Systemic Treatment-Naive
1 recruiting site
Institut d'oncologie du Vall d'Hebron